Comparison of short and long-acting testosterone replacement therapy for better sperm production and testosterone levels in male late-onset hypogonadism
Keywords:
hypogonadism, testosterone, male infertility, late-onset hypogonadismAbstract
Introduction: Testosterone Replacement Therapy (TRT) is the standard treatment for male late-onset hypogonadism. Short-acting and long-acting testosterone are currently available treatments and have been approved by the Food and Drug Administration (FDA). The administration of exogenous testosterone is known to increase sperm production and T levels in men suffering from late-onset hypogonadism. However, limited research compares the efficacy of these two types of TRT. Objective: This study aims to compare the efficacy of short-acting and long-acting testosterone replacement therapy on sperm production and T levels in men suffering from late-onset hypogonadism. Methods: We searched for electronic databases including PubMed, Cochrane Library, EMBASE, Scopus, Web of Science, Allied and Complementary Medicine Database (AMED), and Google using keywords. All studies were evaluated by three independent reviewers who resolved differences by consensus. Results: We identified 21 studies that met our inclusion criteria. After applying the inclusion criteria, only 21 database sources remain for further analysis. Conclusion: Long-acting formulas affect blood more. RCTs show TU boosts libido and testosterone. Male infertility may result from long-acting TU blocking LH and FSH. TRP improves erections by increasing motile sperm and libido. Peanut allergy-related short-acting TRT causes nausea, itching, and injection-site pain.
Downloads
References
Anderson RA. the effects of exogenous testosterone on sexuality and normal male mood. Journal of Clinical Endocrinology & Metabolism. 1992 Dec 1;75(6):1503–7.
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: Endocrine Society * Clinical Practice Guidelines. Journal of Clinical Endocrinology & Metabolism [Internet]. 2018 March 17;103(5):1715–44. Available from: https://academic.oup.com/jcem/article/103/5/1715/4939465
Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G, et al. European Academy of Andrology (EAA) Guidelines on the investigation, treatment, and monitoring of functional hypogonadism in males. Andrology. 2020 March 20;8( 5):970–87.
Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Ellenberg SS, Matsumoto AM, et al. Association of sex hormones with sexual function, vitality, and symptomatic physical function of elderly men with low testosterone levels at baseline in testosterone tests. Journal of Clinical Endocrinology & Metabolism. 2015 March;100(3):1146–55.
Diaz P, Reddy R, Blachman-Braun R, Zucker I, Dullea A, Gonzalez DC, Kresch E, Ramasamy R. Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials. World J Men’s Health. 2022 Apr 22. doi: 10.5534/wjmh.210261. Epub ahead of print. PMID: 35791295.
Donatucci C, Cui Z, Fang Y, Grim D. Long-acting Treatment Patterns of Testosterone Replacement Drugs. Journal of Sexual Medicine. 2014 Aug;11(8):2092–9.
Griffin, P., Aribarg, A., Gui-yuan, Z., … C. J.-I. J. of, & 1996, undefined. (n.d.). Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Elibrary.Ru. Retrieved August 16, 2022, from https://elibrary.ru/item.asp?id=493435
Guidry M, Westfield G, Rogol A, Bryson N. 301 One Year Hematology Safety Natesto (Testosterone) Nasal Gel in Men with Late-onset Hypogonadism. Journal of Sexual Medicine. 2018 February;15(2): S76–7.
Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med. 2013 Jun;10(6):1612-27. doi: 10.1111/jsm.12146. Epub 2013 Apr 3. PMID: 23551886.
Haren M. Effect of oral testosterone 12 months on Testosterone Deficiency Symptoms in symptomatic elderly men with low normal gonadal status. Age and Aging. 2005 January 11;34(2):125–30.
Harle L, Basaria S, Dobs AS. Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother. 2005 Aug;6(10):1751-9. doi: 10.1517/14656566.6.10.1751. PMID: 16086661.27. EMC. Sustanon 250 solution, 250mg/ml for injection - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [cited 2022 August 11]. Available from: https://www.medicines.org.uk/emc/medicine/28840#gref
Hellstrom WJG, Soubra A. Re: Natesto's Effect on Reproductive Hormones, Semen Parameters, and Hypogonadal Symptoms: Single Center, Open Label, Single Arm Trials. European urology. June 2021;79(6):890–1.
Hohl A, Marques MOT, Coral MHC, Walz R. Evaluation of late-onset hypogonadism (andropause) using three different formulations of injectable testosterone. Arquivos Brasileiros de Endocrinologia & Metabologia. 2009 November;53(8):989–95.
Hong JH, Ahn TY. Oral testosterone replacement in Korean patients with PADAM. Aging Male. 2002 Mar;5(1):52-6. PMID: 12040976.
Kamaluddin. (2021). Government and Private Collaboration in Coping with Covid-19 in Sorong City. International Research Journal of Management, IT and Social Sciences, 8(5), 333-341. https://doi.org/10.21744/irjmis.v8n5.1907
Kavoussi PK, Machen GL, Chen SH, Gilkey MS, Chen J, Hamzeh Y, Aston KI, Kavoussi SK. Direct conversion from long-acting testosterone replacement therapy to Natesto allows for spermatogenesis resumption: Proof of concept. Andrologia. 2022 Sep;54(8):e14453. doi: 10.1111/and.14453. Epub 2022 May 6. PMID: 35521891.
Khodamoradi K, Khosravizadeh Z, Parmar M, Kuchakulla M, Ramasamy R, Arora H. Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects. F S Rev. 2021 Jan;2(1):32-42. doi: 10.1016/j.xfnr.2020.11.001. Epub 2020 Nov 17. PMID: 33615283; PMCID: PMC7894643.
Kresch, E., Gonzalez, D., Ory, J., Nackeeran, S., Blachman-Braun, R., Molina, M., & Ramasamy, R. (2021). Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men. Journal of the Endocrine Society, 5(Suppl 1), A758.
Madsen MC, Heijer M den, Pee C, Biermasz NR, Bakker LEH. testosterone in men hypogonadism and transgender males: a systematic review comparing three different preparations. Endocrine Connection [Internet]. 2022 August 1 [cited 2022 August 10];11(8). Available from: https://doi.org/10.1530%2FEC-22-0112
Margiana, R., Pakpahan, C., & Pangestu, M. (2022). A systematic review of retinoic acid in the journey of spermatogonium to spermatozoa: From basic to clinical application. F1000Research 2022 11:552, 11, 552. https://doi.org/10.12688/f1000research.110510.2
Masterson TA, Turner D, Vo D, Blachman-Braun R, Best JC, Westfield G, et al. Effects of Longer Acting Testosterone Therapy vs. Shorter Work on Follicle-Stimulating Hormone and Luteinizing Hormone. Sexual Treatment Reviews. 2021 January;9(1):143–8.
Masterson, T. A., Turner, D., Vo, D., Blachman-Braun, R., Best, J. C., Westfield, G., Bryson, N., & Ramasamy, R. (2021). The Effect of Longer-Acting vs Shorter-Acting Testosterone Therapy on Follicle Stimulating Hormone and Luteinizing Hormone. Sexual Medicine Reviews, 9(1), 143–148. https://doi.org/10.1016/J.SXMR.2020.07.006
Morgentaler A, Dobs AS, Kaufman JM, Miner MM, Shabsigh R, Swerdloff RS, Wang C. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol. 2008 Dec;180(6):2307-13. doi: 10.1016/j.juro.2008.08.126. Epub 2008 Oct 18. PMID: 18930255.
Mulhall JP, Brock GB, Glina S, Baygani S, Donatucci CF, Maggi M. Impact of Total Baseline Testosterone Levels on Successful Treatment of Sexual Dysfunction in Men Taking Tadalafil Once a Day 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials. Journal of Sexual Medicine. 2016 May;13(5):843–51.
Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigens. Sexual medicine [Internet]. 2015;3(3):165–73. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26468380
PubChem. Sustanon 250 [Internet]. pubchem.ncbi.nlm.nih.gov. [cited 2022 August 11]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Sustanon-250
Ramasamy R, Masterson TA, Best JC, Bitran J, Ibrahim E, Molina M, et al. Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: Single Center, Open Label, Single Arm Trial. Journal of Urology. 2020 September;204(3):557–63.
Richardson D, Goldmeier D, Frize G, Lamba H, De Souza C, Kocsis A, et al. Letrozole Versus Testosterone. Pilot Study of a Single Center for HIV-infected men who Had Sex with men on Highly Active Anti-Retroviral Therapy (HAART) with Hypoactive Sexual Desire Disorder and Elevated Levels of Estradiol. Journal of Sexual Medicine [Internet]. 2007 1 March [cited 2021 Feb 26];4(2):502–8. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1743609515315502
S, Francavilla S. Testosterone replacement therapy. Andrology. 2020 Mar 9.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
T'Sjoen G. Perception of males aging symptoms, health, and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology. 2004 Feb;29(2):201–14.
Van den Broeck T, Soebadi MA, Falter A, Raets L, Duponselle J, Lootsma J, Heintz A, Philtjens U, Hofkens L, Gonzalez-Viedma A, Driesen K. Testosterone Induces Relaxation of Human Corpus Cavernosum Tissue of Patients With Erectile Dysfunction. Sexual Medicine. 2020 Mar 1;8(1):114-9.
Wang C, Stephens-Shields AJ, DeRogatis LR, Cunningham GR, Swerdloff RS, Preston P, et al. Validity and Clinically Meaningful Changes in Daily Psychosexual Questionnaires and Derogatis Interviews for Sexual Function Assessment: Results From the Testosterone Trials. Journal of Sexual Medicine. 2018 July;15(7):997–1009.
Westfield G, Kaiser UB, Lamb DJ, Ramasamy R. Short-Acting Testosterone: More Physiological? Borders in Endocrinology [Internet]. 2020 Sep 30 [cited 2022 August 9];11. Available from: https://doi.org/10.3389%2Ffendo.2020.572465
Wibisono, S. (2015). Metabolic Syndrome, Obesity and Testosterone deficiency Why it’s Happen? What’s the Correlated? He 57th Quadruple Symposium, 174–180. https://repository.unair.ac.id/108926/
Wirawan, I. G. B. (2018). Surya Namaskara benefits for physical health. International Journal of Social Sciences and Humanities, 2(1), 43–55. https://doi.org/10.29332/ijssh.v2n1.78
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
